Class II recall: Baxter Healthcare Corporation: Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY

Baxter Healthcare Corporation has issued a Class II recall for Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL), packaged in GALAXY 50 mL Single Dose Containers under NDC 0338-3814-50. The recall notice cites current Good Manufacturing Practice (CGMP) deviations as the reason for the action. No further clinical details were provided in the source notice.

Most relevant for: Patients receiving intravenous clindamycin injections from the recalled batch for bacterial infections or other clinical indications requiring this antibiotic formulation.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.